KAT8

From WikiMD's WELLNESSPEDIA

KAT8 Regulatory NSL Complex Subunit 1 (KAT8), also known as MYST Histone Acetyltransferase 1 (MYST1) or MOZ, YBF2/SAS3, SAS2, and TIP60 protein 1, is a protein that in humans is encoded by the KAT8 gene. KAT8 is a member of the MYST family of histone acetyltransferases (HATs), which play a crucial role in the regulation of gene expression through modification of chromatin structure. This protein is involved in the acetylation of histone H4, a process essential for chromatin remodeling and transcriptional activation.

Function[edit]

KAT8 is a core component of the non-specific lethal (NSL) complex, which is known to acetylate the lysine 16 on histone H4 (H4K16ac), a key epigenetic marker associated with DNA repair, replication, and transcriptional activation. The acetylation of H4K16 plays a significant role in the decondensation of chromatin structure, facilitating access for transcription factors and other regulatory proteins. KAT8 also targets other non-histone proteins for acetylation, indicating its diverse roles in cellular processes beyond transcriptional regulation.

Clinical Significance[edit]

Mutations and dysregulation of KAT8 have been implicated in various human diseases, including cancer. The alteration in histone acetylation patterns due to aberrant KAT8 activity can lead to changes in gene expression profiles, contributing to tumorigenesis and progression. Furthermore, KAT8 is involved in DNA damage response and repair mechanisms, making it a potential target for cancer therapy. Research is ongoing to explore the therapeutic implications of modulating KAT8 activity in cancer and other diseases.

Interactions[edit]

KAT8 interacts with several proteins within the NSL complex, including KANSL1, KANSL2, and KANSL3, which are essential for its HAT activity and proper localization to target genes. It also interacts with other histone modifiers and transcription factors, highlighting its integration into a complex network of regulatory pathways that govern gene expression and cellular function.

See Also[edit]

Stub icon

This gene article is a stub. You can help WikiMD by expanding the page.

External Links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=KAT8&oldid=6533808"